Skip to main content

Peer Review reports

From: Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma

Original Submission
16 Sep 2016 Submitted Original manuscript
21 Sep 2016 Author responded Author comments - Lisenko Katharina
Resubmission - Version 2
21 Sep 2016 Submitted Manuscript version 2
16 Dec 2016 Reviewed Reviewer Report - Raju Kandimalla
3 Jan 2017 Reviewed Reviewer Report - Wei Gao
11 Jan 2017 Author responded Author comments - Lisenko Katharina
Resubmission - Version 3
11 Jan 2017 Submitted Manuscript version 3
12 Jan 2017 Reviewed Reviewer Report - Raju Kandimalla
1 Feb 2017 Reviewed Reviewer Report - Wei Gao
12 Feb 2017 Author responded Author comments - Lisenko Katharina
Resubmission - Version 4
12 Feb 2017 Submitted Manuscript version 4
4 Mar 2017 Reviewed Reviewer Report - Wei Gao
20 Mar 2017 Reviewed Reviewer Report - Shilpee Dutt
18 Apr 2017 Author responded Author comments - Lisenko Katharina
Resubmission - Version 5
18 Apr 2017 Submitted Manuscript version 5
24 Apr 2017 Author responded Author comments - Lisenko Katharina
Resubmission - Version 6
24 Apr 2017 Submitted Manuscript version 6
1 May 2017 Author responded Author comments - Lisenko Katharina
Resubmission - Version 7
1 May 2017 Submitted Manuscript version 7
Publishing
8 May 2017 Editorially accepted
22 May 2017 Article published 10.1186/s12885-017-3332-3

You can find further information about peer review here.

Back to article page